Alector, Inc. (NASDAQ: ALEC)
$1.6600
+0.0250 ( -2.35% ) 502.3K
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
Market Data
Open
$1.6600
Previous close
$1.6350
Volume
502.3K
Market cap
$167.38M
Day range
$1.6350 - $1.7850
52 week range
$1.6100 - $7.7800
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 11 | Jan 10, 2025 |
| 4 | Insider transactions | 1 | Dec 03, 2024 |
| 4 | Insider transactions | 1 | Dec 03, 2024 |
| 4 | Insider transactions | 1 | Dec 03, 2024 |
| 4 | Insider transactions | 1 | Dec 03, 2024 |
| 8-k | 8K-related | 13 | Nov 25, 2024 |
| 8-k | 8K-related | 12 | Nov 14, 2024 |
| 8-k | 8K-related | 12 | Nov 06, 2024 |
| 10-q | Quarterly Reports | 46 | Nov 06, 2024 |
| 4 | Insider transactions | 1 | Oct 10, 2024 |